Crossmark

1319 Next-generation TCR bispecifics (TCER®) targeting peptide-HLA antigens for the treatment of patients with solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1319

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Bunk, Sebastian

Hofmann, Martin

Pszolla, Gabriele

Hutt, Meike

Unverdorben, Felix

Schwoebel, Frank

Aschmoneit, Nadine

Wagner, Claudia

Jaworski, Maike

Schraeder, Christoph

Schuster, Heiko

Missel, Sarah

Weinschenk, Toni

Maurer, Dominik

Reinhardt, Carsten